Growth Metrics

Invivyd (IVVD) Current Assets (2020 - 2025)

Invivyd posted quarterly Current Assets of $247.5 million for Q4 2025, up 145.79% year-on-year from $100.7 million in Q4 2024, and up 125.44% on a QoQ basis from $109.8 million in Q3 2025.

Invivyd (IVVD) has 6 years of Current Assets data on file, last reported at $247.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 145.79% year-over-year to $247.5 million; the trailing twelve-month figure through Dec 2025 stood at $247.5 million (up 145.79% YoY), and the FY2025 full-year result was $247.5 million, up 145.79% from the prior year.
  • Current Assets for Q4 2025 stood at $247.5 million, up from $109.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $680.2 million in Q3 2021 and bottomed at $59.3 million in Q2 2025.
  • The 5-year median for Current Assets is $270.1 million (2023), against an average of $305.5 million.
  • The widest annual swing landed in 2021, when Current Assets soared 425.39%; it then slumped 65.74% in 2025.
  • A 5-year view of Current Assets shows it stood at $616.7 million in 2021, then sank by 38.88% to $376.9 million in 2022, then sank by 40.34% to $224.9 million in 2023, then tumbled by 55.23% to $100.7 million in 2024, then jumped by 145.79% to $247.5 million in 2025.
  • The last three Current Assets figures came in at $247.5 million (Q4 2025), $109.8 million (Q3 2025), and $59.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 10.37 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 37.31 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 73.04 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 11.73 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.21 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.22 Bn
10 Invivyd 208.38 Mn -18.31 Mn - 247.47 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 247.47 Mn
Sep 30, 2025 109.77 Mn
Jun 30, 2025 59.28 Mn
Mar 31, 2025 75.83 Mn
Dec 31, 2024 100.68 Mn
Sep 30, 2024 151.10 Mn
Jun 30, 2024 173.01 Mn
Mar 31, 2024 209.88 Mn
Dec 31, 2023 224.88 Mn
Sep 30, 2023 270.10 Mn
Jun 30, 2023 309.99 Mn
Mar 31, 2023 344.62 Mn
Dec 31, 2022 376.92 Mn
Sep 30, 2022 421.60 Mn
Jun 30, 2022 481.36 Mn
Mar 31, 2022 554.30 Mn
Dec 31, 2021 616.71 Mn
Sep 30, 2021 680.16 Mn
Jun 30, 2021 396.06 Mn
Dec 31, 2020 117.38 Mn